antigen
antigen
Key Insights from BPI 2025 Revealed!
BIOT
**Excerpt:** 🌟 BPI 2025 revealed biotech trends! 🗣️ John & Julianna shared insights. 🎉 GEN's reception was vibrant! 📊 Stay updated! 🔗
Revolutionary Munich Company Doses First Patient with Groundbreaking Cancer Treatment
BIOT
📢 Tubulis from Munich doses first patient with its ADC candidate TUB-040 targeting NaPi2b antigen in ovarian and lung cancer. 🧪
